---
figid: PMC8470931__biomedicines-09-01244-g006
figtitle: RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via
  Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
pmcid: PMC8470931
filename: biomedicines-09-01244-g006.jpg
figlink: /pmc/articles/PMC8470931/figure/biomedicines-09-01244-f006/
number: F6
caption: A schematic of the working mechanism of NSC139021 in glioblastoma. NSC139021
  induces cell cycle arrest via the Skp2-p27/p21-Cyclin E/CDK2-pRb axis and triggers
  apoptosis via activating the p53 signaling. NSC139021 decreases the protein level
  of Skp2, which leads to the accumulation of p27 and p21. Subsequently, p27/p21 enhances
  the inhibition of CDK2, reduces the combination of CDK2 and Cyclin E, and decreases
  the dissociation of Rb and E2F. As the G1/S checkpoint, hyperphosphorylated Rb dissociates
  E2F that downregulates the expression of Cyclin E and forms positive feedback in
  the G1/S transition, and eventually activates the p53 pathway to induce cell apoptosis.
papertitle: RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via
  Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis.
reftext: Min Yu, et al. Biomedicines. 2021 Sep;9(9):1244.
year: '2021'
doi: 10.3390/biomedicines9091244
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: glioblastoma | NSC139021 | cell cycle | Skp2 pathway | proliferation | apoptosis
automl_pathway: 0.9415283
figid_alias: PMC8470931__F6
figtype: Figure
redirect_from: /figures/PMC8470931__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8470931__biomedicines-09-01244-g006.html
  '@type': Dataset
  description: A schematic of the working mechanism of NSC139021 in glioblastoma.
    NSC139021 induces cell cycle arrest via the Skp2-p27/p21-Cyclin E/CDK2-pRb axis
    and triggers apoptosis via activating the p53 signaling. NSC139021 decreases the
    protein level of Skp2, which leads to the accumulation of p27 and p21. Subsequently,
    p27/p21 enhances the inhibition of CDK2, reduces the combination of CDK2 and Cyclin
    E, and decreases the dissociation of Rb and E2F. As the G1/S checkpoint, hyperphosphorylated
    Rb dissociates E2F that downregulates the expression of Cyclin E and forms positive
    feedback in the G1/S transition, and eventually activates the p53 pathway to induce
    cell apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rb
  - ebi
  - E2f2
  - E2f1
  - Skp2
  - DCTN6-p27
  - dap
  - CG9588
  - CycE
  - Cdk2
  - Cdk4
  - LanB2
  - anon-70Db
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - oh
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - SKP2
  - UXT
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCNE1
  - CCNE2
  - CDK2
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
---
